95% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
Anna-Jasmina Donaubauer1,2
Ina Becker1,2
Thomas Weissmann2Birgitta M. Fröhlich1,2
Luis E. Muñoz3Thomas Gryc2Manuel Denzler1,2Oliver J. Ott2Rainer Fietkau2
Udo S. Gaipl1,2*†
Benjamin Frey1,2†- 1Translational Radiobiology, Department of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany
- 2Department of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany
- 3Department of Internal Medicine 3 -Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Universitätsklinikum Erlangen, Erlangen, Germany
By Donaubauer A-J, Becker I, Weissmann T, Fröhlich BM, Muñoz LE, Gryc T, Denzler M, Ott OJ, Fietkau R, Gaipl US and Frey B (2021). 12:740742. doi: 10.3389/fimmu.2021.740742
In the original article, there was an error. The mistake is found in the sentence “While the total number of leukocytes remained unchanged in the peripheral blood, LDRT induced a slight reduction of eosinophils, basophils and plasmacytoid dendritic cells and an increase of B cells.” in the abstract of the article.
As it is correctly stated in the results section of the paper, the eosinophils, the basophils and the plasmacytoid dendritic cells increased, while the B cells were decreased.
A correction has been made to the Abstract:
“While the total number of leukocytes remained unchanged in the peripheral blood, LDRT induced a slight increase of eosinophils, basophils and plasmacytoid dendritic cells and a decrease of B cells.”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: low dose radiation therapy (LDRT), immune status, immunophenotyping, chronic degenerative and inflammatory diseases, subjective pain level, x-rays
Citation: Donaubauer A-J, Becker I, Weissmann T, Fröhlich BM, Muñoz LE, Gryc T, Denzler M, Ott OJ, Fietkau R, Gaipl US and Frey B (2022) Corrigendum: Low Dose Radiation Therapy Induces Long-Lasting Reduction of Pain and Immune Modulations in the Peripheral Blood - Interim Analysis of the IMMO-LDRT01 Trial. Front. Immunol. 13:859489. doi: 10.3389/fimmu.2022.859489
Received: 21 January 2022; Accepted: 25 January 2022;
Published: 07 February 2022.
Edited and Reviewed by:
Michal Tomcik, Institute of Rheumatology, Prague, CzechiaCopyright © 2022 Donaubauer, Becker, Weissmann, Fröhlich, Muñoz, Gryc, Denzler, Ott, Fietkau, Gaipl and Frey. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Udo S. Gaipl, dWRvLmdhaXBsQHVrLWVybGFuZ2VuLmRl
†These authors have contributed equally to this work and share senior authorship